Postmortem Cannabis Testing: A Validated Extraction Does Not Reconstruct Life Before Death

A method that successfully extracts THC from postmortem specimens establishes analytical capability. It does not independently establish how the deceased behaved before death or whether cannabis caused an accident.

What the laboratory developed

Researchers developed a liquid–liquid extraction and gas chromatography–mass spectrometry method for THC and THC-COOH, applying it to 41 postmortem samples. The workflow used separate extraction conditions for parent THC and its carboxy metabolite, with derivatization for the latter.

This was human-specimen analytical research, not controlled dosing of living participants. The study assessed detection, calibration, precision, accuracy and recovery. Those endpoints address measurement performance rather than functional impairment.

The exact matrix still matters

Although the paper describes postmortem blood, its preparation section states that plasma was separated by centrifugation when possible. That qualification matters when evaluating a result attributed simply to “blood.” Whole blood and separated plasma are different preparations and should be identified accurately in a case report.

The authors discuss practical difficulties with degraded postmortem samples, including problems passing material through solid-phase extraction cartridges. A method’s practical usefulness in that setting does not eliminate specimen heterogeneity.

Validation is not a causal experiment

The method showed acceptable analytical precision and accuracy under its validation conditions. The case application demonstrated that the workflow could be used on actual submissions. It did not validate a conversion from a postmortem concentration to a living person’s earlier concentration or performance.

THC and THC-COOH must also remain separate: parent drug and an inactive carboxy metabolite do not answer the same toxicological question. The presence of either requires interpretation with collection site, timing, preparation and other case evidence.

Questions an opinion should answer

Ask which specimen was actually extracted, whether the laboratory’s own validation covers its condition, and which inference the analyst proposes. An accurate concentration can support exposure evidence while leaving impairment, timing and cause of death unresolved. Analytical success should not be used to fill those evidentiary gaps.

For context, see our discussion of THC concentrations and the separate question of impairment.

Primary research

Ivan Álvarez-Freire and colleagues. Simple Method for the Determination of THC and THC-COOH in Human Postmortem Blood Samples by Gas Chromatography—Mass Spectrometry. Molecules (2023). DOI: 10.3390/molecules28083586.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Other Medications Changed THC/CBD Spray Exposure in Different Directions

The effect of another medication on THC/CBD exposure depends on the drug and the pathway involved. A human interaction study found lower cannabinoid exposure with rifampicin, higher exposure with ketoconazole, and no significant pharmacokinetic change with omeprazole under the tested conditions. Three separate crossover comparisons Stott and colleagues studied 36…

Spread the love

Read Article: Other Medications Changed THC/CBD Spray Exposure in Different Directions

An Intermediate CBD Stress Response Was Not a Significant Placebo Difference

A CBD group’s average response can fall between placebo patients and healthy controls without demonstrating a significant CBD-versus-placebo benefit. A study of social stress in people at clinical high risk of psychosis illustrates this statistical distinction. Stress hormones and subjective symptoms were separate endpoints Participants at clinical high risk received…

Spread the love

Read Article: An Intermediate CBD Stress Response Was Not a Significant Placebo Difference

Two-Dimensional Cannabis GC–MS Testing Needs Correctly Timed Transfer Windows

Adding a second chromatography column can improve cannabinoid separation while introducing a new failure point: the analyte must reach the second column during the correct transfer window. A plasma assay study showed why those windows require verification. More separation brought more timing requirements Karschner and colleagues developed two-dimensional gas chromatography–mass…

Spread the love

Read Article: Two-Dimensional Cannabis GC–MS Testing Needs Correctly Timed Transfer Windows

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us